Literature DB >> 17270493

Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.

Dirk J van Veldhuisen, John J V McMurray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17270493     DOI： 10.1016/j.ejheart.2007.01.004

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  17 in total

1.  Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.

Authors:  Larry A Allen; G Michael Felker; Mandeep R Mehra; Jun R Chiong; Stephanie H Dunlap; Jalal K Ghali; Daniel J Lenihan; Ron M Oren; Lynne E Wagoner; Todd A Schwartz; Kirkwood F Adams
Journal:  J Card Fail       Date:  2009-12-29       Impact factor: 5.712

Review 2.  Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.

Authors:  Dirk J van Veldhuisen; Stefan D Anker; Piotr Ponikowski; Iain C Macdougall
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

Review 3.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 4.  The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina; Doron Schwartz
Journal:  Clin Exp Nephrol       Date:  2008-08-01       Impact factor: 2.801

5.  Managing anemia in patients with chronic heart failure: what do we know?

Authors:  Ankur Sandhu; Sandeep Soman; Michael Hudson; Anatole Besarab
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

6.  Relationship between anemia and health care costs in heart failure.

Authors:  Larry A Allen; Kevin J Anstrom; John R Horton; Linda K Shaw; Eric L Eisenstein; G Michael Felker
Journal:  J Card Fail       Date:  2009-12       Impact factor: 5.712

Review 7.  Heart failure and anemia: mechanisms and pathophysiology.

Authors:  Inder S Anand
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

Review 8.  Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.

Authors:  B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2007-09

Review 9.  Approaches to the treatment of anaemia in patients with chronic heart failure.

Authors:  Clare L Murphy; John J V McMurray
Journal:  Heart Fail Rev       Date:  2008-04-08       Impact factor: 4.214

10.  The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study.

Authors:  Jocelyn Anderson; Liam G Glynn; John Newell; Alberto A Iglesias; Donal Reddan; Andrew W Murphy
Journal:  BMC Cardiovasc Disord       Date:  2009-11-12       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.